Clinical 

PRANCIS

Prognostication RAdioresistant Nasopharynx CarcInoma Survival 


PRANCIS is a prognostic index to help personalise risk stratification, in order to salvage radiotherapy for radioresistant Nasopharynx Cancer (NPC) patients. The tool was made publicly available in collaboration with MedLever, to facilitate wider clinical implementation and also aid physicians in clinical decision making. 

 

In this area of study, we have a strong collaboration with Sun Yat-Sen University Cancer Center to build robust models and personalize risk stratification and therapies in patients.